SCHEMBL5504166

SCHEMBL5504166

Cc1nc(CC(N)=O)sc1-c1cncc(NS(=O)(=O)c2ccccc2)n1

nearest known ligand 0.47

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
PIK3CD O00329 16/20 0.47
PIK3CB P42338 16/20 0.47
PIK3CG P48736 15/20 0.47
PIK3CA P42336 14/20 0.47
GAA P10253 3/20 0.43
KDM4E B2RXH2 1/20 0.43
LMNA P02545 1/20 0.43
ALDH1A1 P00352 2/20 0.41
MEN1 O00255 2/20 0.41
KMT2A Q03164 2/20 0.41
USP2 O75604 1/20 0.41
MAPT P10636 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
HSD17B10 Q99714 1/20 0.41
CYP2C9 P11712 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL927012 0.80 PIK3CG (0.59) PIK3CDPIK3CBPIK3CGPIK3CAGAA
SCHEMBL926176 0.67 PIK3CD (0.58) PIK3CDPIK3CBPIK3CGPIK3CAGAA
SCHEMBL10119823 0.67 HSD11B1 (0.48) PIK3CAKDM4ELMNAALDH1A1MEN1
SCHEMBL5508446 0.65 ATAD2 (0.39) PIK3CDPIK3CBPIK3CGPIK3CAKDM4E
SCHEMBL926185 0.64 PIK3CG (0.57) PIK3CDPIK3CBPIK3CGPIK3CAGAA
SCHEMBL925179 0.64 GAA (0.58) PIK3CDPIK3CBPIK3CGPIK3CAGAA
SCHEMBL4778320 0.63 KMT2A (0.47) LMNAALDH1A1MEN1KMT2AMAPT
SCHEMBL48824 0.63 ALDH1A1 (0.46) PIK3CDPIK3CBPIK3CGPIK3CALMNA
SCHEMBL22792087 0.63 KDM4E (0.52) KDM4ELMNAALDH1A1MEN1KMT2A
SCHEMBL2835239 0.62 PIK3CG (0.64) PIK3CGGAAKDM4ELMNAALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1841763-A1 5-HETEROARYL THIAZOLES AND THEIR USE AS PI3K INHIBITORS AstraZeneca AB (SE) 2007-10-10 EP disclosed
WO-2006051270-A1 5-HETEROARYL THIAZOLES AND THEIR USE AS P13K INHIBITORS ASTRAZENECA AB (SE) 2006-05-18 WO disclosed